Morgan Stanley analyst John Glass maintains Wendy’s (NASDAQ:WEN) with a Equal-Weight and raises the price target from $24 to $26.
Piper Sandler Maintains Overweight on Harpoon Therapeutics, Lowers Price Target to $15
Piper Sandler analyst Joseph Catanzaro maintains Harpoon Therapeutics (NASDAQ:HARP) with a Overweight and lowers the price target from $27 to $15.